Single dose oral aceclofenac for postoperative pain in adults
- PMID: 19588436
- PMCID: PMC4170891
- DOI: 10.1002/14651858.CD007588.pub2
Single dose oral aceclofenac for postoperative pain in adults
Abstract
Background: Aceclofenac is the prodrug of the non-steroidal anti-inflammatory drug (NSAID) diclofenac, widely used to treat acute and chronic pain. There are no known systematic reviews of its analgesic efficacy in acute postoperative pain. This review sought to evaluate the efficacy and safety of oral aceclofenac in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties.
Objectives: To assess the efficacy of single dose oral aceclofenac in acute postoperative pain, and any associated adverse events.
Search strategy: We searched The Cochrane Library (Issue 1, 2009), MEDLINE via Ovid (1966 to March 2009); EMBASE via Ovid (1980 to March 2009); the Oxford Pain Relief Database (1950 to 1994); and reference lists of articles.
Selection criteria: Randomised, double-blind, placebo-controlled clinical trials of oral aceclofenac for relief of acute postoperative pain in adults.
Data collection and analysis: Two review authors independently assessed trial quality and extracted data. The area under the "pain relief versus time" curve was used to derive the proportion of participants with paracetamol plus codeine and placebo or paracetamol alone experiencing least 50% pain relief over 4 to 6 hours, using validated equations. The number needed to treat to benefit (NNT) was calculated using 95% confidence intervals (CI). The proportion of participants using rescue analgesia over a specified time period, and time to use of rescue analgesia, were sought as additional measures of efficacy. Information on adverse events and withdrawals was also collected.
Main results: Searches identified only one study (217 participants total), which used oral aceclofenac 150 mg in patients with established postoperative pain. Aceclofenac 150 mg could not be distinguished from placebo, though ibuprofen 400 mg was distinguished from placebo.
Authors' conclusions: In the absence of evidence of efficacy for oral aceclofenac in acute postoperative pain (at least at 150 mg single dose), its use in this indication is not justified. Because trials clearly demonstrating analgesic efficacy in the most basic of acute pain studies are lacking, use in other indications should be evaluated carefully. Given the large number of effective drugs available in this and similar classes of analgesics, there is no urgent research agenda required to demonstrate the effective dose of aceclofenac in acute postoperative pain.
Conflict of interest statement
SD, RAM & HJM have received research support from charities, government and industry sources at various times. RAM and HJM have consulted for various pharmaceutical companies. RAM, and HJM have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. Support for this review came from Oxford Pain Research, the NHS Cochrane Collaboration Programme Grant Scheme, and NIHR Biomedical Research Centre Programme.
Update of
- doi: 10.1002/14651858.CD007588
References
References to studies included in this review
Seymour 1998 {published data only}
-
- Seymour RA, Frame J, Negus TW, Hawkesford JE, Marsden J, Matthew IR. The comparative efficacy of aceclofenac and ibuprofen in postoperative pain after third molar surgery. The British Journal of Oral and Maxillofacial Surgery 1998;36(5):375‐9. - PubMed
References to studies excluded from this review
Chalini 2005 {published data only}
-
- Chalini S, Raman U. Comparative efficacy of aceclofenac and etoricoxib in post extraction pain control: randomized control trial. Indian journal of Dental Research 2005;16(2):47‐50. - PubMed
Movilia 1989 {published data only}
-
- Movilia PG. Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post‐episiotomy pain. Drugs Under Experimental and Clinical Research 1989;15(1):47‐51. - PubMed
Presser Lima 2006 {published data only}
Yscla 1988 {published data only}
-
- Yscla A. Aceclofenac and paracetamol in episiotomal pain. Drugs Under Experimental and Clinical Research 1988;14(7):491‐4. - PubMed
Additional references
Barden 2004a
-
- Barden J, Edwards JE, McQuay HJ, Wiffen PJ. Relative efficacy of oral analgesics after third molar extraction. British Dental Journal 2004;197(7):407‐11. - PubMed
Barden 2004b
-
- Barden J, Edwards JE, McQuay HJ, Andrew Moore R. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain 2004;107(1‐2):86‐90. - PubMed
Batlle‐Gualda 2007
-
- Batlle‐Gualda E, Román Ivorra J, Martín‐Mola E, Carbonell Abelló J, Linares Ferrando LF, Tornero Molina J, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double‐blind 6‐week randomized controlled trial. Osteoarthritis Cartilage 2007;15(8):900‐8. [DOI: 10.1016/j.joca.2007.02.008] - DOI - PubMed
Berg 1999
-
- Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)‐1/‐2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)‐6 in vitro. Inflammation Research 1999;48:369‐79. - PubMed
Clarke 2009
Collins 1997
-
- Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72:95‐7. - PubMed
Collins 2001
-
- Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ. Seeking a simple measure of analgesia for mega‐trials: is a single global assessment good enough?. Pain 2001;91(1‐2):189‐94. - PubMed
Cook 1995
Cooper 1991
-
- Cooper SA. Single‐dose analgesic studies: the upside and downside of assay sensitivity. The Design of Analgesic Clinical Trials. Advances in Pain Research Therapy 1991;18:117‐24.
Derry 2008
Derry C 2009a
Derry C 2009b
Derry P 2009
Fitzgerald 2001
-
- FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase‐2. New England Journal of Medicine 2001;345(6):433‐42. - PubMed
Hawkey 1999
-
- Hawkey CJ. Cox‐2 inhibitors. Lancet 1999;353(9149):307‐14. - PubMed
Hinz 2003
-
- Hinz B, Rau T, Auge D, Werner U, Ramer R, Rietbrock S, Brune K. Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Clinical Pharmacology and Therapeutics 2003;74(3):222‐35. - PubMed
Hinz 2004
-
- Hinz B, Brune K. Pain and osteoarthritis: new drugs and mechanisms. Current Opinion in Rheumatology 2004;16(5):628‐33. - PubMed
Jadad 1996a
-
- Jadad AR, Carroll D, Moore RA, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2‐3):239‐46. - PubMed
Jadad 1996b
-
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
L'Abbe 1987
-
- L'Abbe KA, Detsky AS, O'Rourke K. Meta‐analysis in clinical research. Annals of Internal Medicine 1987;107:224‐33. - PubMed
Letzel 2006
McQuay 2005
Moore 1996
-
- Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66(2‐3):229‐37. - PubMed
Moore 1997
-
- Moore A, Moore O, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain 1997;69(3):311‐5. - PubMed
Moore 1998
-
- Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything‐large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209‐16. - PubMed
Moore 2003
-
- Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003.
Moore 2005
-
- Moore RA, Edwards JE, McQuay HJ. Acute pain: individual patient meta‐analysis shows the impact of different ways of analysing and presenting results. Pain 2005;116(3):322‐31. - PubMed
Moore 2006
-
- Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006.
Morris 1995
Pareek 2006
-
- Pareek A, Chandanwale AS, Oak J, Jain UK, Kapoor S. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double‐blind comparative clinical trial versus diclofenac ‐ an Indian experience. Current Medical Research and Opinion 2006;22(5):977‐88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
